Company profile

Nxera Pharma Co., Ltd.

EDINET
E00981
Securities
4565
Industry
Pharmaceutical
Latest annual securities report
2026-03-25 Annual Securities Report PDF HTML
Latest financial report
2026-08-07 Semiannual Securities Report PDF HTML
Latest filing
2026-08-07 Amended Securities Registration Statement PDF HTML
Compare this company

Industry position

Pharmaceutical

View details
Profitability Above average Current Top 35% 5-year trend Deteriorating
Financial strength Weak Based on Equity ratio Current Bottom 19% 5-year trend Broadly stable
Growth Strong Current Top 22% 5-year trend Deteriorating
Cash generation Strong Current Top 24% 5-year trend Deteriorating

Latest half-year results

H1 FY2026

2026/01/01 - 2026/06/30

Consolidated · IFRS · Cumulative YTD

For H1 FY2026, revenue was ¥18.91 billion, up 25.3% year over year. Operating income was ¥1.88 billion, up 168.3% year over year. Net income was ¥1.59 billion, up 150.7% year over year.

Revenue ¥18.91B up 25.3% year over year
Operating income ¥1.88B up 168.3% year over year
Net income ¥1.59B up 150.7% year over year
Operating cash flow ¥3.98B
Free cash flow -¥372M
Total assets ¥132.38B
Total equity ¥64.8B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · IFRS · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2025

Consolidated IFRS

Revenue reached ¥29.62 billion, up 2.7% year over year. Operating income was -¥8.46 billion, down 56.0% year over year. Operating margin was -28.6%. Net income was -¥12.53 billion, down 159.0% year over year. ROE was -20.5%; equity ratio was 45.3%; free cash flow was ¥2.76 billion.

Revenue ¥29.62B up 2.7% year over year
Operating income -¥8.46B down 56.0% year over year
Net income -¥12.53B down 159.0% year over year
Total assets¥134.79B
Total equity¥61B
Operating cash flow-¥2.67B
Free cash flow¥2.76B

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

Comparison sample varies by metric

Profitability Above average

Operating margin Top 40% / ROE Top 38%

Financial strength Weak
Based on Equity ratio

Equity ratio Bottom 85%

Growth Strong

Revenue growth Top 39% / 3-year revenue CAGR Top 15%

Cash generation Strong

Operating cash flow margin Top 39% / Free cash flow margin Top 20%

Profitability Industry position history Deteriorating
2025 Bottom 33% 2024 Bottom 40% 2023 Bottom 35% 2022 Top 37% 2021 Top 38%
Financial strength Industry position history Broadly stable
2025 Bottom 19% 2024 Bottom 17% 2023 Bottom 13% 2022 Bottom 29% 2021 Bottom 28%
Growth Industry position history Deteriorating
2025 Top 34% 2024 Top 9% 2023 Top 48% 2022 Bottom 48% 2021 Top 3%
Cash generation Industry position history Deteriorating
2025 Top 49% 2024 Bottom 31% 2023 Bottom 23% 2022 Top 0% 2021 Top 4%
Profitability Operating margin -28.6% Industry median -155.7% Top 40% Comparison sample 20
Profitability ROE -20.5% Industry median -29.2% Top 38% Comparison sample 32
Financial strength Equity ratio 45.3% Industry median 71.4% Bottom 85% Comparison sample 32
Growth Revenue growth +2.7% Industry median -1.5% Top 39% Comparison sample 21
Growth 3-year revenue CAGR +23.9% Industry median -1.0% Top 15% Comparison sample 20
Cash generation Operating cash flow margin -9.0% Industry median -157.8% Top 39% Comparison sample 21
Cash generation Free cash flow margin 9.3% Industry median -167.1% Top 20% Comparison sample 21

Annual financial data

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Share price Market cap Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2025 Consolidated IFRS 29615000000 -8462000000 -14950000000 -12530000000 -12530000000 -9466000000 134787000000 60997000000 60997000000 60997000000 -2668000000 5430000000 -16028000000 2762000000 20365000000 -138.8 90496735 0.4525436429 0.453 -0.2054199387 -0.0929614874 -0.285733581 -0.4230964038 -0.0900894817 0.0932635489 0.0270504595 -0.5603909275 -2.2067782068 -1.5899131873 -0.1103050865 -0.1097667766 0.6543145893 2.1400377913 -1.3384884739 1.2212963705 -0.3688793851 -1.5741839763 0.0066057633 0.0213903743 382
FY2024 Consolidated IFRS 28835000000 -5423000000 -4662000000 -4838000000 -4838000000 319000000 151498000000 68518000000 68518000000 68518000000 -7718000000 -4763000000 -6854000000 -12481000000 32268000000 -53.92 89902858 0.452269997 0.452 -0.070609183 -0.031934415 -0.1880700538 -0.1677822091 -0.2676608289 -0.4328420323 1.2587341376 0.4307159353 0.5634831461 0.3274016405 -0.0362600033 0.0255650352 -0.463682913 0.9253342948 -1.1418196114 0.8192835631 -0.3423417915 0.3815095205 0.0050989093 0.0685714286 374
FY2023 Consolidated IFRS 12766000000 -9526000000 -10680000000 -7193000000 -7193000000 -1121000000 157198000000 66810000000 66810000000 66810000000 -5273000000 -63791000000 48329000000 -69064000000 49065000000 -87.18 89446777 0.4250054072 0.425 -0.1076635234 -0.0457575796 -0.746200846 -0.5634497885 -0.4130502898 -5.4099953 -0.1800372535 -3.7724097788 -10.9072356215 -19.8298429319 0.5811983866 0.1531690141 -1.5298432476 -62.1610738255 10.8892981379 -7.2814006367 -0.2628123263 -19.6282051282 0.0918365523 0.7326732673 350
FY2022 Consolidated IFRS 15569000000 3436000000 1078000000 382000000 382000000 -255000000 99417000000 57936000000 57936000000 57936000000 9952000000 1043000000 -4887000000 10995000000 66557000000 4.68 456.84 2138.0112 175152783280.1760 81923230 0.5827574761 0.583 0.0065934825 0.0038424012 0.2206949708 0.0245359368 0.6392189608 0.7062110604 -0.1209914182 -0.0898013245 1.4896073903 -0.6243854474 0.0250760427 0.0081436626 0.4026779422 2.7517985612 -1.4393598849 0.4912518649 0.1076772014 -0.6264964086 0.0049671536 0.0202020202 202
FY2021 Consolidated IFRS 17712000000 3775000000 433000000 1017000000 1017000000 5623000000 96985000000 57468000000 57468000000 57468000000 7095000000 278000000 11123000000 7373000000 60087000000 12.53 151.96 1904.0588 155215666940.9808 81518316 0.592545239 0.593 0.0176968052 0.0104861577 0.2131323397 0.0574186992 0.4005758808 0.4162714544 1.0031667044 3.067887931 -0.7330456227 -0.3123732252 0.2683580723 0.0971153663 0.5186215753 2.8533333333 -0.4514745044 0.6304732419 0.5018746251 -0.3324453916 0.0114420881 0.0421052632 198
FY2020 Consolidated IFRS 8842000000 928000000 1622000000 1479000000 1479000000 661000000 76465000000 52381000000 52381000000 52381000000 4672000000 -150000000 20278000000 4522000000 40008000000 18.77 95.9 1800.043 145076496033.504 80596128 0.6850323677 0.685 0.0282354289 0.0193421827 0.1049536304 0.1672698485 0.5283872427 0.511422755 -0.0908903969 1.4166666667 2.0374531835 0.0328212291 0.3490649259 0.1620854132 0.3577448416 0.3902439024 3.9118322803 0.4153364632 1.6021463415 0.0037433155 0.0457097269 0.1656441718 190
FY2019 Consolidated IFRS 9726000000 384000000 534000000 1432000000 1432000000 2367000000 56680000000 45078000000 45075000000 45075000000 3441000000 -246000000 -6964000000 3195000000 15375000000 18.7 116.1 2171.07 167331173375.52 77073136 0.7952540579 0.795 0.0317692734 0.0252646436 0.0394818014 0.1472342176 0.3537939543 0.3285009254 2.3864902507 1.0737263565 1.2395850761 -0.0391103124 0.0841330543 1.8613266583 0.9123931624 -2.0705467372 1.4696457445 -0.1804371002 1.2385204082 -0.0355029586 163
FY2018 Consolidated IFRS 2872000000 -7243000000 -5977000000 -5977000000 -7618000000 58987000000 41577000000 41577000000 -3995000000 -2808000000 -2268000000 -6803000000 18760000000 -78.4 0.7048502212 0.705 -0.1437573659 -0.1013274111 -2.0811281337 -1.3910167131 -2.3687325905 1.9823468328 -2.8141126909 -3.9193415638 -0.2023286319 -0.1791150862 -33.7391304348 0.507713885 -1.0959106863 -0.1691012201 -0.4162491832 -0.1461988304 169
FY2017 Consolidated IFRS 963000000 -1899000000 -1215000000 -1215000000 692000000 73949000000 50649000000 50649000000 -115000000 -5704000000 23647000000 -5819000000 32137000000 -68.4 0.684917984 0.685 -0.0239886276 -0.0164302425 -1.261682243 -0.1194184839 -6.0425752856 -0.2470680219 -1.1429862209 -23.0909090909 0.4086597074 0.6961020695 -1.0094790636 -1.8084687346 5.8397462137 -1.5760815761 1.0812771194 -21.7272727273
FY2016 Consolidated IFRS 1279000000 13281000000 55000000 55000000 6399000000 52496000000 29862000000 29862000000 12132000000 -2031000000 -4886000000 10101000000 15441000000 3.3 0.5688433404 0.569 0.0018418056 0.0010476989 0.0430023456 9.4855355747 7.8975762314

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp